Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The role of topoisomerase IIα and HER-2 in predicting sensitivity to anthracyclines in breast cancer patients

16 Sept 2009

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer therapeutics and mechanisms
Share to HER2/EGFR in Cancer Research
Share to Monoclonal and Polyclonal Antibodies Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 19758759
DOI: 10.1016/j.ctrv.2009.08.006

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The role of topoisomerase IIα and HER-2 in predicting sensitivity to anthracyclines in breast cancer patientsPMID 19758759Read ↗

Differential expression of the topoisomerase IIα and β genes in human breast cancersSemantic proximity Read ↗

The HER2 amplicon in breast cancer: Topoisomerase IIA and beyondSemantic proximity Read ↗

Triple negative breast cancer - current status and prospective targeted treatment based on HER1 (EGFR), TOP2A and C-MYC gene assessmentSemantic proximity Read ↗

ERBB2 and TOP2A in Breast Cancer: A Comprehensive Analysis of Gene Amplification, RNA Levels, and Protein Expression and Their Influence on Prognosis and PredictionSemantic proximity Read ↗

Human topoisomerase II alpha as a prognostic biomarker in cancer chemotherapySemantic proximity Read ↗

Simultaneous Amplification of HER-2 (ERBB2) and Topoisomerase II&#945; (TOP2A) Genes - Molecular Basis for Combination Chemotherapy in CancerSemantic proximity Read ↗

Prognostic molecular markers and neoadjuvant therapy response in anthracycline-treated breast cancer patientsSemantic proximity Read ↗

Correlation between complete response to anthracycline-based chemotherapy and topoisomerase II-α gene amplification and protein overexpression in locally advanced/metastatic breast cancerSemantic proximity Read ↗

O‐GlcNAcylation promotes topoisomerase IIα catalytic activity in breast cancer chemoresistanceSemantic proximity Read ↗

Alteration of topoisomerase II-alpha gene in human breast cancer: association with responsiveness to anthracycline-based chemotherapy.Semantic proximity Read ↗

Topoisomerase IIalpha-positive and BRCA1-negative phenotype: association with favorable response to epirubicin-based regimens for human breast cancers.Semantic proximity Read ↗

Expression of topoisomerase II-α in triple negative breast cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.